Ferrous citrate fe 59 side effects by duration, gender and age - a phase IV clinical study of FDA data
There are no side effects reported by people who take Ferrous citrate fe 59. The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Ferrous Citrate Fe 59?
Ferrous citrate fe 59 has active ingredients of ferrous citrate, fe-59. It is used in anemia. Currently, eHealthMe is studying from 117 Ferrous citrate fe 59 users.
Do you take Ferrous citrate fe 59?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on ferrous citrate, fe-59 (the active ingredients of Ferrous citrate fe 59) and Ferrous citrate fe 59 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Ferrous citrate fe 59:
- Ferrous citrate fe 59 (117 reports)
All Ferrous citrate fe 59 side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Imbruvica and Agitation Aggravated - 2 seconds ago
- Ibuprofen and Muscle Haemorrhage - 14 seconds ago
- Loprox and Methylprednisolone drug interaction - 14 seconds ago
- Crixivan and Gallbladder Disorder - 28 seconds ago
- Ramipril and Limb Asymmetry - 36 seconds ago
- Ezetimibe and Metoprolol Tartrate drug interaction - 36 seconds ago
- Acular and Appetite - Decreased - 38 seconds ago
- Acular and Appetite Decreased - 38 seconds ago
- Ortho-Cept and Rashes - 39 seconds ago
- Celebrex and Rash Scaly - 47 seconds ago